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What's new? 
 Diabetes impacts driving safety through the influence of hypoglycaemia and 
diabetic retinopathy. 
 Diabetic peripheral neuropathy (DPN) affects tactile sensation, proprioception 
and muscle strength primarily in the feet and the lower limbs. 
 Drivers with DPN showed reduced ankle position sense, impaired muscle 
function and an altered use of the accelerator pedal. 
 Despite driving more slowly, drivers with DPN experienced more loss-of-
control events than other drivers, but demonstrated a residual ability to improve 
with practice. 
 Control of the accelerator pedal and overall driving performance are affected by 
DPN, but this research opens up opportunities to devise technological solutions 
and training programmes to help people with DPN drive more safely. 
 
Abstract 
Aim To investigate whether the sensory-motor impairment attributable to diabetic 
peripheral neuropathy would affect control of the accelerator pedal during a driving 
simulator task.  
Methods A total of 32 active drivers, 11 with diabetic peripheral neuropathy (mean ± 
SD age 67±5.0 years), 10 with diabetes but no neuropathy (diabetes group; mean  ± SD 
age 62±10 years), and 11 healthy individuals without diabetes (healthy group; mean ± 
SD age 60±11 years), undertook a test on a dynamometer to assess ankle plantar flexor 
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driving simulator task. The following variables were measured: maximal ankle plantar 
flexor muscle strength; speed of strength generation (Nm/s); and ankle joint 
proprioception (ankle repositioning error, degrees). In the driving simulator task, 
driving speed (mph), accelerator pedal signal (degrees) and the duration of specific 
'loss-of-control events' (s) were measured during two drives (Drive 1, Drive 2). 
Results Participants with diabetic peripheral neuropathy had a lower speed of strength 
generation (P<0.001), lower maximal ankle plantar flexor muscle strength (P<0.001) 
and impaired ankle proprioception (P=0.034) compared to healthy participants. The 
diabetic peripheral neuropathy group drove more slowly compared with the healthy 
group (Drive 1 P=0.048; Drive 2 P=0.042) and showed marked differences in the use 
of the accelerator pedal compared to both the diabetes group (P=0.010) and the healthy 
group (P=0.002). Participants with diabetic peripheral neuropathy had the longest 
duration of loss-of-control events, but after one drive, this was greatly reduced 
(P=0.023). 
Conclusions Muscle function, ankle proprioception and accelerator pedal control are 
all affected in people with diabetic peripheral neuropathy, adversely influencing driving 
performance, but potential for improvement with targeted practice remains possible. 
Introduction 
Diabetic peripheral neuropathy (DPN) is one of the commonest complications of 
diabetes [1,2], with consequences for reduced or absent tactile sensation, vibration 
perception, proprioception, muscle strength and joint range of motion [2–7]. The 
cutaneous sensory loss, together with sensory-motor dysfunction, are most pronounced 
in the feet, and progress up to affect more proximal parts of the lower limbs, following 
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strength of the ankle dorsal and plantar flexors is reduced by ~30% compared to people 
with diabetes but no neuropathy [10]. Nerve conduction velocities of peroneal and sural 
nerves significantly correlate with muscle response latencies, while a loss of movement 
perception, predominantly at the ankle joint, is attributable to altered function of muscle 
spindles [11–13]. The detrimental effects of diabetes and DPN in affecting 
neuromuscular and motor function with consequences for daily life activities has been 
reported in terms of marked unsteadiness, slower speed of strength generation and 
altered muscle activation timing while walking on level ground and on stairs [14,15].  
In addition to locomotor tasks, driving is another common daily activity where the 
integration of motor and sensory function is important for successful performance. 
Previous studies investigating driving performance in diabetes have focused on the 
influence of hypoglycaemia (resulting in an impaired ability to drive), diabetic 
retinopathy (impairing the clear vision needed to operate a motor vehicle) and DPN, 
affecting the ability to feel foot pedals which could impact the ability to drive safely 
[16,17]. Concerning this last issue, a few recent studies have demonstrated that people 
with DPN had slower mean brake response times and have an increased frequency of 
abnormally delayed braking reactions compared with both people with diabetes but no 
DPN and healthy individuals, when driving on a simulator [18,19]. Possible reasons for 
this could be that sensory neuropathy impairs the ability to feel the pedals, or the ability 
to move the feet efficiently between the accelerator and brake pedals; thus, the impaired 
neuromuscular function of the plantar flexor muscles, together with the lack of 
adequate proprioceptive feedback, could influence driving performance [20].  
Whilst previous studies of driving in diabetes have focused primarily on the influence 
of hypoglycaemia and diabetic retinopathy, no previous research has investigated the 
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during driving, and the overall effect these factors have on driving performance. We 
hypothesized that people with DPN would have impaired sensory-motor function 
around the ankle joint that would impact adequate control of the accelerator pedal 
during driving and, in turn, influence driving performance. The aim of the present study, 
therefore, was to investigate sensory-motor function in people with diabetes and DPN 
and driving performance using a driving simulator.   
Methods  
Participants 
Thirty-two participants, all active drivers holding a UK driving licence and driving for 
not less than 30 min every day, were recruited into three groups: 11 participants with 
DPN (mean ± SD age 67 ± 5.0 years and BMI 32 ± 4.2 kg/m
2
; nine men, two women), 
10 participants with diabetes but no peripheral neuropathy (mean ± SD age 62±10 years 
and BMI 31±5.2 kg/m
2
; nine men, one woman) and 11 healthy age-matched 
participants without diabetes (mean ± SD age 60 ± 11 years and BMI 27 ± 4.4 kg/m
2
; 
nine men, two women). All participants gave their written informed consent to 
participate in the study, which received ethical approval from all relevant bodies. The 
principal inclusion criteria were: diagnosis of diabetes (diabetes group) or absence of 
diabetes in the healthy group (confirmed via random blood glucose test <7.8 mmol/l); 
holding a current full UK driving licence; driving a car at least once per week; and age 
>20 years (Table 1). The principal exclusion criteria were: active foot ulcers on either 
foot; lower limb amputation involving more than two toes on the right foot (foot 
applied to the accelerator pedal); dementia; visual acuity worse than 20/50; and 
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Neuropathy assessment  
The presence and severity of DPN was measured using the modified Neuropathy 
Disability Score, a composite test of multiple sensory modalities, together with the 
detection of the vibration perception threshold using a neurothesiometer (Bailey 
Instruments Ltd, Manchester, UK) [1]. Based on these tests, participants with diabetes 
were divided into groups as follows: DPN group:  Neuropathy Disability Score ≥6, 
vibration perception threshold ≥25 Volts; and diabetes group:  Neuropathy Disability 
Score ≤3, vibration perception threshold ≤15 Volts. These tests were also performed in 
the healthy group to confirm the absence of peripheral neuropathy. 
Design 
During a 2.5-h experimental session, participants underwent a series of tests which 
were always presented in the same order. Firstly, information was taken about 
participants’ medical history, and subsequently a maximum isometric contraction of the 
ankle plantar flexor muscles and an ankle proprioception test were performed on an 
isokinetic dynamometer (Cybex Norm, Rosemont, IL, USA). Visual acuity was 
assessed using a 'Snellen chart' and a random blood glucose test was undertaken to 
confirm the absence of diabetes in healthy individuals and to avoid any hypo- or 
hyperglycaemic influence during the subsequent driving task in those participants with 
diabetes. Participants with diabetes had blood glucose levels within the range 4.5–20 
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Procedure 
Motor function variables 
An isokinetic dynamometer (Cybex Norm) was used to assess the speed of strength 
generation and the maximal strength of the ankle plantar flexor muscles in addition to 
ankle proprioception function. The dynamometer was integrated with a data acquisition 
system Labchart 8
® 
(AD Instruments, Sydney, NSW, Australia). Only the right foot and 
lower limb were selected for dynamometry testing because this is the side used to 
operate the accelerator pedal in all cars. The tests were performed according to 
standardized procedures. The ankle position selected to perform all motor function tests 
was 10° of plantar flexion, an angle corresponding to a mid-position of the  accelerator 
pedal when driving [21]. Participants were positioned prone on the dynamometer couch 
and their right foot secured to the footplate of the dynamometer using non-elastic straps.  
After several standardized submaximal contractions as a warm-up, participants 
completed a maximum effort isometric strength test of the plantar flexor muscles of the 
right leg at 10° plantar flexion. Participants were instructed to push against the 
dynamometer footplate as hard and as fast as possible, similar to an emergency brake 
when driving, and to maintain the contraction for ~3–5 s. This test included two trials, 
with a rest of 2–3 min in between each trial to avoid any fatigue effect.  
With regard to proprioception function, the knowledge of the position (sense) and the 
ability to reproduce a specific joint position was objectively quantified recording the 
error value in degrees, the 'ankle repositioning error' [22]. We recorded the error value 
(i.e. the discrepancy between the target ankle joint position and the actual position 
participants selected in the trial). A higher error value indicates poorer proprioception 
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flexion) and remained at this position for 5 s to demonstrate the target angle to the 
participant. Subsequently, the dynamometer foot plate was then moved into 
dorsiflexion and plantar flexion to disturb position sense. Participants were then asked 
to reproduce the same ankle joint position and maintain it for at least ~3 s while it was 
recorded. The proprioception test included some practice trials at different ankle joint 
angle positions to facilitate comprehension of the task, with a 1-min rest in between to 
avoid any learning effects. Participants were unable to see their feet during the 
experiment. 
Driving simulator task  
The driving simulator consisted of a 42-inch plasma screen, a steering wheel giving 
realistic feedback when turned, accelerator and brake pedals (automatic gear change), 
and an adjustable car seat. The setup was the same as that used in previous studies 
[23,24]. Participants were invited to find a comfortable driving position, with 
adjustment of the simulator construct as needed for individual preference. Specific 
instructions were given to participants to drive safely, as they would in a real car. 
Verbal instruction and a demonstration describing how to use the simulator were also 
given. The task consisted of a driving environment simplified by the absence of other 
vehicles and pedestrians, taken from the Colin McRae Rally 2 simulation (Codemaster, 
Leamington Spa, UK). The view was of the road ahead through the windscreen, with 
addition of the speedometer in the bottom right-hand corner. The route was a 3.1-mile 
winding country road, which included gentle and sharp bends with few straight sections. 
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Data analysis 
Motor function variables  
The speed of strength generation at the ankle was measured as the rate at which joint 
torque was developed, which reflects the speed of force being developed by the ankle 
plantar flexor muscles [15]. The speed of strength generation was assessed as the 
gradient of the torque–time (Δtorque/Δtime) curve over the first 150 ms after the onset 
of contraction. Onset of muscle contraction was defined as the time point at which the 
torque curve exceeded baseline torque by 5 Nm.  
The maximal strength of the plantar flexor muscles was defined by the value of the 
'peak torque' (Nm), i.e. the highest value exerted around the ankle joint, during a 
maximal isometric contraction of the plantar flexor muscles [25].  
Proprioception function was assessed using the ankle repositioning error, which 
quantified the proprioception function using an error score obtained by the difference 
between the target position (10° plantar flexion) and the position reached by the 
participant. We considered the mean of three trials to be representative of the global 
proprioception function: higher error values correspond to lower proprioception 
function.  
Driving simulator task 
We analysed data from two repeats of the 3.10-mile driving course, quantifying driving 
speed (mph) and producing frequency distribution plots of the accelerator pedal 
position signal (degrees). This signal was recorded over a range from 0°, when no load 
was applied to the pedal, to a maximum of –20°, when the pedal was completely 
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pedal was pushed down by different amounts. We considered each complete drive as a 
whole in order to observe the pattern of pedal usage and produced 'difference plots' by 
subtracting the frequency distribution of the healthy group or the diabetes group from 
the frequency distribution of the DPN group to identify and highlight any differences 
between the people with DPN and the other two groups. These difference plots, 
therefore, highlighted how differently drivers with DPN used the accelerator pedal 
when compared to drivers in the diabetes and healthy groups.  
Lastly, the analysis of the steering wheel signal (degrees) for which we detected 
specific characteristics in terms of amplitude and repetitive frequency (Fig. 1) allowed 
us to estimate the total duration of any instance that we defined as a loss-of-control 
event. Loss-of-control events consisted of an extreme, unjustified and inappropriate use 
of the steering wheel, i.e. movements that reached the full range of motion of the 
steering wheel and/or exhibited a repetitive frequency, during which the driver 
continued to maintain this exaggerated motion. The total duration of these loss-of-
control events for each group was then normalized to the number of participants in each 
group (seconds per person).   
Statistics  
The motor function variables (maximal ankle plantar flexor strength, speed of strength 
generation, and ankle proprioception), driving speed and loss-of-control events were 
analysed using one-way ANOVA, with Bonferroni post hoc tests to assess differences 
between groups (DPN, diabetes and healthy groups). We used a paired sample t-test to 
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Differences between the accelerator pedal frequency distribution plots between groups 
(DPN vs diabetes group; or DPN vs healthy group) were assessed using an independent 
samples Student’s t-test.  Data were analysed using parametric statistics as the data 
were normally distributed. All statistical tests were performed using SPSS statistical 
package version 22 (IBM Corp., Chicago, IL, USA), with P values <0.05 taken to 
indicate statistical significance.  
Results  
Motor function variables  
The mean ± SD speed of strength generation was significantly lower in the DPN group 
(P<0.001) and the diabetes group (P=0.002) when compared to healthy participants 
[DPN group: 80.30 ± 61.37 n/ms; diabetes group: 104.66 ± 43.36 n/ms; healthy group: 
252.65 ± 28.37 n/ms (Fig. 2a)]. The maximal plantar flexor muscle strength values 
were significantly lower (P<0.001) only in the DPN group vs the healthy group [DPN 
group: 22±62; diabetes group: 39.98±14.33; healthy group: 54.44±20.31 (Fig. 2b)]. A 
lower ankle proprioception function, corresponding to a higher error value, was found 
in the DPN group (P=0.034) vs the healthy group [DPN group: 3.54±2.29; diabetes 
group: 3.30±1.63; healthy group: 1.45±1.34 (Fig. 2c)]. No significant differences were 
found between the diabetes and the healthy group for these two variables (maximal 
strength, P=0.76; proprioception, P=0.81). 
Driving simulator task 
Analysis of the study drives showed a significantly slower mean ± SD driving speed in 
the DPN  group compared to the healthy group in both the first (P=0.048; DPN group: 
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and the second drive (P=0.042; DPN group: 18.55 ± 4.15 mph; diabetes group: 21.56 ± 
3.97 mph; healthy group: 24.06 ± 4.15 mph). Furthermore, only the healthy group had a 
significantly faster driving speed during the second drive compared to their first drive 
(P=0.013; Fig. 3a). The mean ± SD duration of loss-of-control events was significantly 
higher in the DPN group compared to both the diabetes (P=0.040) and healthy groups 
(P=0.012) during the first drive (DPN group: 59.07±64.71 s; diabetes group: 
13.02±15.46 s; healthy group: 5.86±15.68 s). During the second drive, there was only a 
significant difference in the duration of loss-of-control events between the DPN and the 
healthy group (P=0.049; DPN group: 13.83 ± 20.23 s; diabetes group: 7.08 ± 8.11 s; 
healthy group: 0 ± 0 s) The DPN group was the only group that significantly reduced 
the duration of loss-of-control events during the second drive when compared to the 
first one (P=0.023; Fig. 3b).  
The accelerator pedal 'difference plots' highlight significant differences in control of the 
accelerator pedal of the DPN group compared to both the diabetes (pedal position 
angle: 0–0.5°, P=0.010; 1–1.5°, P=0.039; 1.5–2°, P=0.044) and healthy groups [pedal 
position angle: 0–0.5°, P=0.002; 3–3.5°, P=0.041; 3.5–4°, P=0.036; 4–4.5°, P=0.046  
(Fig. 4)]. Participants with DPN spent more of the time driving with the accelerator 
pedal closer to, or at the extremes of its range, that is, both barely depressed and at the 
other extreme, approaching full depression to the floor. They spent much less of the 
time with the pedal in its mid-range.  
Discussion 
In the present study we show for the first time how sensory-motor deficits associated 
with DPN influence the use of the accelerator pedal during a driving simulator task. 
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accelerator pedal range: either barely depressed at all, or near fully depressed to the 
floor. Furthermore, the DPN group experienced more loss of control (longer duration, 
in seconds) while driving compared to the participants with diabetes but without 
neuropathy and compared to the healthy participants. From a positive perspective, only 
the participants with DPN improved significantly from the first to the second drive in 
reducing the duration of loss-of-control events, highlighting that this might be 
modifiable by training.  
In both drives, we found that the DPN group had a very different approach to the use of 
the accelerator pedal from that of both the diabetes and healthy groups. The DPN group, 
when driving, spent most of the time with the accelerator pedal depressed by ≤1°, i.e. 
much more time hardly pushing at all on it, while in the same drive, they also spent 
more time using the more extreme depressed position of the pedal right to the floor, 
tending to skip the middle range of pedal compression.  The healthy participants and 
those with diabetes but no neuropathy, in contrast, used the extremes of pedal position 
less of the time. Rather, there was a gradual decrease in the time the pedal spent more 
and more pushed down, representing a more homogeneous, smoothly graded use of the 
middle range of the pedal.  
Another interesting finding concerns driving speed; participants with DPN drove 
significantly more slowly than the healthy participants of the same age without diabetes, 
a mechanism already observed in older cohorts, attributed to a desire to compensate for 
their slower reaction times [26,27]. Interestingly, despite the fact that they were driving 
more slowly, the duration of loss-of-control events that occurred during the first drive 
was significantly higher in the DPN group compared to the healthy group. Although 
this observation indicates the potential of DPN to impair driving ability, analysis of the 
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greatly reduce the loss-of-control events, indicating residual ability for improving 
driving performance, and the potential for practice or structured training to recover the 
lost ability in a functional way. Standard sensory-motor function tests, which all drivers 
undertook, confirmed the detrimental effects of the nerve damage attributable to 
diabetes in affecting plantar flexor muscle function and ankle proprioception, which 
may be the underlying mechanisms for the impaired control of the accelerator pedal. 
Participants with DPN had lower maximal ankle plantar flexor muscle strength values 
and impaired ankle proprioception function compared to the healthy group. As regards 
speed of strength generation, the participants with diabetes both with and without DPN 
developed less strength in the first 150 ms of a maximal isometric contraction of plantar 
flexor muscles compared to healthy participants. It has been demonstrated that the most 
disabling consequence of DPN is the continuous loss of motor axons, which, in 
combination with insufficient reinnervation, results in denervation of muscle fibres, 
responsible for the muscular atrophy and muscle weakness at the ankle [28]; thus, the 
formation of very large motor units leads to a progressive reduction in force steadiness 
and fine motor control in this population [6]. This might explain the observed loss of 
continuously graded control of the accelerator pedal when driving. 
These observations support our initial hypothesis that the ability to know where the foot 
is in space (proprioception) and a reduced tactile sensation of the pedal against the foot, 
could be two major and important factors in achieving precise control and appropriate 
pressure on the accelerator pedal during driving.   
We acknowledge that the present sample size may be considered relatively small, 
however, tests used to assess motor control were highly reproducible and there was 
adequate statistical power to detect significant changes in the main variables, as 
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variables as a result of unknown differences between the groups examined that we 
might have been unable to control for. In this respect, a future longitudinal study may 
be useful in confirming the present findings. 
Whilst people with DPN might represent an increased risk with regard to driving safely, 
our findings indicate that drivers with DPN potentially retain a residual ability to 
improve, but further research will determine whether this potential for improvement 
can be realized through a specific, standardized and systematic training programme. 
Through future research we intend to use the knowledge of the specific pattern of 
impairment to devise solutions that help drivers with DPN to drive more safely for 
longer, which would confer benefits with regard to quality of life and autonomy.    
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FIGURE 1 Example from a single participant’s steering wheel signal to illustrate how the 
'loss-of-control events' (quantified in seconds) were identified from the steering wheel signal 
(degrees) during driving. Portions of the wheel signal (Start–End) that abruptly exceeded the 
range seen during normal driving in terms of amplitude and/or frequency were identified. 
These periods were then summed and quantified as the total duration (seconds) in one single 
drive, and then normalized for the number of participants in each group (to obtain seconds 
per person).  
FIGURE 2  (a) Speed of strength generation (SSG). (b) Maximal strength values. (c) Ankle 
repositioning error (ARE). All motor function testing was performed on the right leg using a 
joint angle of 10° plantar flexion in the three groups: healthy participants, participants with 
diabetes but no neuropathy, and participants with diabetic peripheral neuropathy (DPN). 
Values are mean and SD, n=32. *Significantly different, P<0.05. 
FIGURE 3 (a) Driving speed (mph) during the first drive (black bars) and second drive 
(white bars) for each group: healthy participants; participants with diabetes but no 
neuropathy; and participants with diabetic peripheral neuropathy (DPN). (b) Duration of the 
loss-of-control events (seconds per person) during the first (Drive 1) and second (Drive 2) 
drives. Values are mean and SD, n=32. *Significantly different, P<0.05. 
FIGURE 4  Accelerator pedal position frequency distribution plots. Each bar represents the 
time (seconds) the accelerator pedal spent in a specific position, from 0 (no pressure on the 
pedal) to a maximum of –20° (maximal pressure applied on the pedal) during driving. The 
graphs on the left side represent the original frequency distribution plots of each group: 










This article is protected by copyright. All rights reserved. 
with diabetic peripheral neuropathy (DPN); on the right side the 'difference plots' are 
obtained by subtracting one group plot from another. The change in colour indicates the 
significantly different DPN group’s pedal use when compared to those of the Healthy and 
Diabetes groups (P<0.005). The upper panel represents the comparison between DPN and 
Healthy groups, while the lower panel represents the comparison between DPN and Diabetes 
groups. 
 
Table 1 Characteristics of the healthy, diabetes but no neuropathy, and diabetic peripheral neuropathy 
groups included in the study 
 
Group Participants, n Age, years VPT, Volts Driving licence, 
years 
Healthy 11 60 ± 11 7 ± 3 40 ± 8 
Diabetes 10 62 ± 10 11 ± 6 43 ± 9 
DPN 11 67 ± 5 44 ± 10 45 ± 9 
 
DPN, diabetic peripheral neuropathy; VPT, vibration perception threshold. 
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